CURRENT OPINION IN LIPIDOLOGY

Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.

Journal Title

CURR OPIN LIPIDOL

ISSN / eISSN

0957-9672 / 1473-6535

Aims and Scope

With its easy-to-digest reviews on important advances in world literature, Current Opinion in Lipidology offers expert evaluation on a wide range of topics from six key disciplines including nutrition and metabolism, genetics and molecular biology, and hyperlipidaemia and cardiovascular disease. Published bimonthly, each issue covers in detail the most pertinent advances in these fields from the previous year. This is supplemented by a section of Bimonthly Updates, which deliver an insight into new developments at the cutting edge of the disciplines covered in the journal.

Subject Area

BIOCHEMISTRY & MOLECULAR BIOLOGY

ENDOCRINOLOGY & METABOLISM

PERIPHERAL VASCULAR DISEASE

CiteScore

6.70

View Trend

CiteScore Ranking

Category	Quartile	Rank
Medicine - Cardiology and Cardiovascular Medicine	Q1	#64/354
Medicine - Nutrition and Dietetics	Q2	#34/131
Medicine - Endocrinology, Diabetes and Metabolism	Q2	#65/232
Medicine - Genetics	Q2	#104/328
Medicine - Molecular Biology	Q2	#172/380
Medicine - Cell Biology	Q2	#128/274

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
BIOCHEMISTRY & MOLECULAR BIOLOGY - SCIE	Q2
ENDOCRINOLOGY & METABOLISM - SCIE	Q2
PERIPHERAL VASCULAR DISEASE - SCIE	Q2

H-index

116

Country/Area of Publication

ENGLAND

Publisher

Lippincott Williams and Wilkins Ltd.

Publication Frequency

Bimonthly

Annual Article Volume

Open Access

Contact

LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621

Popular journals in the same field
Recent articles

Cardiovascular disease prevention in heterozygous familial hypercholesterolemia: how important is a healthy diet in the era of long-lasting cholesterol-lowering drug therapies?: (2023) Gabrielle Roy, Jean-Philippe Drouin-Chartier

Angiopoietin-like 3 inhibition and the liver: less is more?: (2023) Reindert F. Oostveen, G. Kees Hovingh, Erik S.G. Stroes

Sweet swell of burning fat: emerging role of high-density lipoprotein in energy homeostasis: (2023) Anatol Kontush, Maximiliano Martin, Fernando Brites

Circulating cell-free DNA and its association with cardiovascular disease: what we know and future perspectives: (2023) Steffen Ullitz Thorsen, Kristine Frøsig Moseholm, Frederik Banch Clausen

High-density lipoprotein functionality, cardiovascular health, and patterns of alcohol consumption: new insights and future perspectives: (2023) Marta Trius-Soler, Kenneth J. Mukamal, Marta Guasch-Ferré

Triglyceride-rich lipoprotein cholesterol and cardiovascular risk: (2023) Selin Bilgic, Alan T. Remaley, Allan D. Sniderman

Predictors of cardiovascular risk in familial hypercholesterolemia: (2023) Manuel Jesús Romero-Jiménez, María Elena Mansilla-Rodríguez, Eva Nadiejda Gutiérrez-Cortizo

The pathophysiology of excess plasma-free cholesterol: (2023) Baiba K. Gillard, Corina Rosales, Antonio M. Gotto, Henry J. Pownall

Ups and downs in PCSK9 inhibition in the cardiovascular arena: a review: (2023) Daniel J. McClintick, Robert P. Giugliano

Strategies of improving adherence to lipid-lowering therapy in patients with atherosclerotic cardiovascular disease: (2023) Dean G. Karalis

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now